MHRA Drug Safety Update – December 2018

MHRA Drug Safety Update – December 2018

December 18, 2018

Date issued 18th December 2018

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 5 December 2018) has been published and includes articles on:

  • Oral lidocaine-containing products for infant teething: only to be available under the supervision of a pharmacist
  • Valproate medicines: are you acting in compliance with the pregnancy prevention measures?
  • Emollients: new information about risk of severe and fatal burns with paraffin-containing and paraffin-free emollients
  • Direct-acting antivirals for chronic hepatitis C: risk of hypoglycaemia in patients with diabetes
  • Hydrocortisone muco-adhesive buccal tablets: should not be used off-label for adrenal insufficiency in children due to serious risks

To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.

 

 

 



Posted in:


More Latest News >

Ask PSNC: Quality Payments FAQs

The team at PSNC has received a number of queries on the Quality Payments Scheme. Below are some of the questions asked in recent weeks....